Cover ImageSALE
市場調查報告書

心臟生物標記的全球市場:2017年∼2021年

Global Cardiac Biomarkers Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 318286
出版日期 內容資訊 英文 96 Pages
訂單完成後即時交付
價格
Back to Top
心臟生物標記的全球市場:2017年∼2021年 Global Cardiac Biomarkers Market 2017-2021
出版日期: 2017年10月10日 內容資訊: 英文 96 Pages
簡介

全球心臟生物標記市場,預計從2017年到2021年期間以12.97%的年複合成長率成長。

本報告提供全球心臟生物標記市場相關調查分析,市場概要,各市場區隔考察,各地區考察,推動市場的要素與課題,主要企業等相關彙整。

第1章 摘要整理

第2章 報告的範圍

第3章 市場調查的方法

第4章 簡介

  • 市場趨勢的概要

第5章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 市場區隔:各技術

  • 市場概要
  • 傳統臨床檢驗
  • POC檢驗

第7章 市場區隔:各產品

  • 市場概要
  • 全球肌鈣蛋白(cTnI, cTnT)檢測市場
  • 其他檢測市場
  • 全球BNP/NT-proBNP檢測市場
  • 全球CK-MB檢測市場
  • 全球肌紅蛋白檢測市場

第8章 市場區隔:各終端用戶

  • 市場概要
  • 醫院、診療所
  • 臨床檢驗室

第9章 各地區市場區隔

  • 市場概要
  • 南北美洲
  • 歐洲/中東/非洲
  • 亞太地區

第10章 決策結構

第11章 市場成長的促進要素與課題

第12章 市場趨勢

第13章 業者情勢

  • 競爭模式
  • Abbott
  • Alere
  • F. Hoffmann-La Roche
  • 值得注意的企業
  • 其他主要供應商

第14章 附錄

  • 簡稱一覽

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR14643

About Cardiac Biomarkers

Cardiac biomarkers are the substances used to detect the risk stratification of a patient with chest pain or suspected acute coronary syndrome (ACS). These biomarkers are released in blood when the heart is damaged or stressed. The tests that are carried out by introducing the cardiac biomarkers to the bloodstream help in determining the risks of associated heart conditions such as cardiac ischemia, ACS, myocardial infarction, and other associated heart diseases.

Technavio's analysts forecast the global cardiac biomarkers market to grow at a CAGR of 12.97% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiac biomarkers market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Cardiac Biomarkers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • Alere
  • F. Hoffmann-La Roche

Other Prominent Vendors

  • Advanced ImmunoChemical
  • AgPlus Diagnostics
  • AZSense
  • BD
  • BG Medicine
  • BioLegend
  • bioMerieux
  • Bio-Rad Laboratories
  • BODITECH MED
  • CAVADIS
  • Cisbio Bioassays
  • Creative Diagnostics
  • Critical Diagnostics
  • Cruinn Medical
  • DiaDexus
  • Enzo Life Sciences
  • Lepu Medical
  • LifeSign
  • LSI Medience
  • Merck
  • Monobind
  • Myriad RBM
  • NeoClone
  • NOWDiagnostics
  • Olink
  • Randox Laboratories
  • Response Biomedical
  • Signosis
  • Thermo Fisher Scientific
  • Tosoh Europe
  • Trinity Biotech
  • Trivitron Healthcare
  • Wondfo

Market driver

  • Increasing use of cardiac biomarkers
  • For a full, detailed list, view our report

Market challenge

  • Dominance of top vendors
  • For a full, detailed list, view our report

Market trend

  • Increased clinical trials
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by technology

  • Market overview
  • Conventional laboratory testing
  • POC testing

PART 07: Market segmentation by product

  • Market overview
  • Global troponin (cTnI, cTnT) assay market
  • Global others assay market
  • Global BNP & NT-proBNP assay market
  • Global CK-MB assay market
  • Global myoglobin assay market

PART 08: Market segmentation by end-user

  • Market overview
  • Hospitals and clinics
  • Diagnostic laboratories

PART 09: Geographical segmentation

  • Market overview
  • Cardiac biomarkers market in Americas
  • Cardiac biomarkers market in EMEA
  • Cardiac biomarkers market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges

  • Market drivers
  • Market challenges

PART 12: Market trends

  • Increased clinical trials
  • Increasing use of cardiac biomarkers in POC testing
  • Emerging cardiac biomarkers

PART 13: Vendor landscape

  • Competitive landscape
  • Abbott
  • Alere
  • F. Hoffmann-La Roche
  • Key companies to watch
  • Other prominent vendors

PART 14: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Advantages associated with cardiac biomarkers
  • Exhibit 02: Market overview of global cardiac biomarkers market 2016
  • Exhibit 03: Global cardiac biomarkers market 2016-2021 ($ millions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Overview of global cardiac biomarkers market by technology 2016
  • Exhibit 06: Global cardiac biomarkers market by conventional laboratory testing 2016-2021 ($ millions)
  • Exhibit 07: Global cardiac biomarkers market by POC testing 2016-2021 ($ millions)
  • Exhibit 08: Overview of global cardiac biomarkers market by product 2016
  • Exhibit 09: Global troponin (cTnI, cTnT) assay market 2016-2021 ($ millions)
  • Exhibit 10: Global others assay market 2016-2021 ($ millions)
  • Exhibit 11: Global BNP & NT-proBNP assay market 2016-2021 ($ millions)
  • Exhibit 12: Global CK-MB assay market 2016-2021 ($ millions)
  • Exhibit 13: Global myoglobin assay market 2016-2021 ($ millions)
  • Exhibit 14: Overview and strategy of global cardiac biomarkers market by end-users 2016
  • Exhibit 15: Buying criteria of end-users in global cardiac biomarkers market 2016
  • Exhibit 16: Global cardiac biomarkers market by geography 2016 and 2021
  • Exhibit 17: Overview of cardiac biomarkers market in Americas
  • Exhibit 18: Cardiac biomarkers market in Americas 2016-2021 ($ millions)
  • Exhibit 19: Overview of cardiac biomarkers market in EMEA
  • Exhibit 20: Cardiac biomarkers market in EMEA 2016-2021 ($ millions)
  • Exhibit 21: Overview of cardiac biomarkers market in APAC
  • Exhibit 22: Cardiac biomarkers market in APAC 2016-2021 ($ millions)
  • Exhibit 23: Market analysis for the increasing cardiac diseases worldwide
  • Exhibit 24: Average cost of cardiac biomarkers
  • Exhibit 25: Clinical trials and their impact
  • Exhibit 26: Competitive structure analysis of global cardiac biomarkers market 2016
  • Exhibit 27: Market penetration of various cardiac biomarkers providers 2016
  • Exhibit 28: Strategic success factors of companies in global cardiac biomarkers market 2016
  • Exhibit 29: Abbott: Strength assessment
  • Exhibit 30: Abbott: Strategy assessment
  • Exhibit 31: Abbott: Opportunity assessment
  • Exhibit 32: Alere: Strength assessment
  • Exhibit 33: Alere: Strategy assessment
  • Exhibit 34: Alere: Opportunity assessment
  • Exhibit 35: F. Hoffmann-La Roche: Strength assessment
  • Exhibit 36: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 37: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 38: Danaher: Company assessment
  • Exhibit 39: Siemens: Company assessment
Back to Top